✦ LIBER ✦

Combination therapy with bevacizumab and temsirolimus in squamous cell carcinoma of the head and neck

✍ Scribed by Bhatt, Vijaya Raj; Ganti, Apar Kishor

Book ID: 122696402
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 201 KB
Volume: 49
Category: Article
ISSN: 1368-8375
DOI: 10.1016/j.oraloncology.2013.04.001

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Squamous cell carcinoma of the head and

Squamous cell carcinoma of the head and neck: combined therapy: Surgery and postoperative irradiation

✍ Rodney R. Million 📂 Article 📅 1979 🏛 Elsevier Science 🌐 English ⚖ 260 KB

New therapies in squamous cell carcinoma

New therapies in squamous cell carcinoma of the head and neck: is the future in combined therapies?

✍ Maurice Schneider 📂 Article 📅 2008 🏛 Springer-Verlag 🌐 English ⚖ 50 KB

Targeted therapies in squamous cell carc

Targeted therapies in squamous cell carcinoma of the head and neck

✍ Kathryn A. Gold; Ho-Young Lee; Edward S. Kim 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 170 KB 👁 3 views

## Abstract Head and neck cancer is a challenging disease that is expected to account for greater than 500,000 new cases worldwide in 2008. Toxicity has impeded advances in chemotherapy and radiation for head and neck cancer, and the prognosis for patients with recurrent and/or metastatic disease r

Combination therapy of surgical resectio

Combination therapy of surgical resection and afterloading in patients with advanced head and neck squamous cell carcinoma

✍ F. Schiefke; G. Hildebrandt; B. Frerich 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 144 KB

Novel therapies in metastatic head and n

Novel therapies in metastatic head and neck squamous cell carcinoma

✍ Anne S. Tsao 📂 Article 📅 2009 🏛 Frontline Medical Communications, Inc. 🌐 English ⚖ 88 KB

Pharmacodynamic evaluation of temsirolim

Pharmacodynamic evaluation of temsirolimus in patients with newly diagnosed advanced-stage head and neck squamous cell carcinoma

✍ Oleksandr Ekshyyan; Glenn M. Mills; Timothy Lian; Nazanin Amirghahari; Xiaohua R 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 244 KB 👁 1 views

## Abstract ## Background: Activation of the mammalian target of rapamycin (mTOR) pathway in surgical margins of head and neck squamous cell carcinoma (HNSCC) is a predictor of recurrence and patients with minimal residual disease may benefit from adjuvant therapy with temsirolimus, an mTOR inhibi